Yanan Bicon Pharmaceutical Listed Company Posted 1.1 Billion Yuan Net Loss in 2022

Yanan Bicon Pharmaceutical Listed Company (延安必康制药股份有限公司) (002411.SZ) reported a net loss of 1.1 billion yuan in 2022, widening 59.9% year-on-year.

Meanwhile, the company posted 8.1 billion yuan in revenue, up 5.8% year-on-year.

At the end of the reporting period, it had 14.9 billion yuan in total assets and 8.7 billion yuan in total liabilities, with a liability-to-asset ratio of 58.5%.